FDA approves blood test to detect colon cancer for those at 'average risk'

Category: Health

The FDA has approved the Shield blood test for colorectal cancer screening in individuals aged 45 and older with average risk. While it offers a less invasive alternative to colonoscopies, it has a higher false positive rate and lower detection rates for large polyps. The test detects DNA from tumors in blood samples and aims to improve screening rates for colorectal cancer.

Keywords: FDA approval, colorectal cancer, blood test

Source: ABC News - Breaking News, Latest News and Videos

Update At: 7/30/2024

Related Sources

Widespread Panic reveals guitarist Jimmy Herring diagnosed with tonsil cancer

Jimmy Herring, lead guitarist of Widespread Panic, has been diagnosed with stage 1 tonsil cancer. The band announced the diagnosis and stated that Herring will begin treatment immediately, with expectations for a full recovery. As a result, Widespread Panic is canceling upcoming shows in Asheville, North Carolina, and will provide refunds to ticketholders. The band expressed gratitude for the support during this time.

USA Today

‘The Widespread Panic’ Halts Concert Due To Medical Crisis

Widespread Panic announced guitarist Jimmy Herring's stage 1 tonsil cancer diagnosis, leading to the cancellation of upcoming concert dates. The band expressed their sadness and assured fans of Herring's expected full recovery while detailing refund policies for ticket holders.

The Daily Caller

OHSU coronavirus (COVID-19) response

OHSU defines vaccination statuses as 'fully vaccinated' and 'up to date' based on CDC guidelines. The institution has administered over 496,000 vaccine doses and continues to provide testing and vaccination services, particularly for underserved communities. OHSU is actively involved in managing COVID-19 responses, including a Long COVID-19 Program and telemedicine services, while also addressing health disparities exacerbated by the pandemic.

OHSU News

Sleep Disruptions Up Susceptibility to COVID-19

Preexisting sleep disturbances, including obstructive sleep apnea, insomnia, and abnormal sleep duration, significantly increase vulnerability to COVID-19, hospitalization, mortality, and long COVID. A meta-analysis of over 8 million individuals revealed that these disturbances are often overlooked as risk factors. Younger adults and men are particularly at higher risk. The study emphasizes the need for early intervention for sleep issues to mitigate adverse COVID-19 outcomes.

Medscape

Study finds veterinary diagnostic laboratories played crucial roles in COVID-19 response

Veterinary diagnostic labs in the U.S. significantly contributed to human health during the COVID-19 pandemic by providing testing and supporting public health interventions. A study from Cornell University highlights their role in filling testing gaps and emphasizes the need for collaboration between animal and human health sectors to prepare for future pandemics.

DVM 360

COVID-19

CSL received approval from Japan's MHLW for ARCT-154, a self-amplifying mRNA COVID-19 vaccine for adults, enhancing its portfolio of vaccines against respiratory viral diseases.

CSL Limited

Biden tests negative for COVID-19, White House says

President Joe Biden has tested negative for COVID-19 after experiencing mild symptoms. He was previously positive while campaigning in Las Vegas and has been prescribed antiviral medication. The White House confirmed he continues to perform his presidential duties and will be monitored for any recurrence of illness. COVID-19 cases are rising in some areas, prompting discussions about seasonal patterns and vaccine recommendations.

LiveNOW from FOX

Mini lungs make major COVID-19 discoveries possible

Researchers have discovered that SARS-CoV-2 can infect more types of lung cells than previously known, including those lacking viral receptors. They also found that the lung can initiate an inflammatory antiviral response independently when exposed to the virus. This research is particularly relevant as COVID-19 cases rise in San Diego and across the U.S.

unmc.edu

Europe Sleep Apnea Devices Market Research 2024-2032: Upward Thrust in Patient Empowerment to Spur Demand

The Europe sleep apnea devices market is projected to grow from US$ 1.81 billion in 2023 to US$ 3.53 billion by 2032, driven by an aging population and increasing prevalence of sleep apnea. Factors such as obesity, lifestyle choices, and a rise in patient empowerment are contributing to this growth. The demand for portable monitoring devices and home sleep testing is increasing, with collaborations between manufacturers and sleep clinics enhancing patient care. Sleep labs play a crucial role in diagnosing sleep apnea, providing essential services for effective treatment.

Yahoo Finance

Listeria outbreak linked to deli meat causes 2 deaths

CDC is investigating a nationwide listeria outbreak linked to deli meats, with 28 hospitalizations and 2 deaths reported. Listeria monocytogenes can contaminate foods and poses a higher risk to vulnerable populations. The agency advises reheating deli meats to 165°F to kill germs and emphasizes the importance of cleaning surfaces that may have come into contact with contaminated products.

The Daily Briefing